This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a Université Laval directory, so their publications, courses and email address may be missing. Find their university profile.
Research
Latest funding
- $1,262,250
Développement translationnel de l'AIMZ-938 comme thérapie de précision pour les cancers colorectaux réfractaires aux traitements
CIHR · 2026 · Principal investigator
- $891,226
L'AIMZ-938, un nouveau promédicament anticancéreux pour le traitement des cancers du sein humain réfractaires aux traitements actuels et exprimant le cytochrome P450 1A1
CIHR · 2021 · Co-investigator
- $497,250
Validation of Highly Potent Substituted Phenyl Alkylureas as Antipsoriatic Agents
CIHR · 2017 · Nominated PI
Développement translationnel de l'AIMZ-938 comme thérapie de précision pour les cancers colorectaux réfractaires aux traitements
Principal investigators: Fortin, Sébastien; Benoit-Biancamano, Marie-Odile; C.-Gaudreault, René; Diorio, Caroline; Droit, Arnaud; Durocher, Francine; Moreau, Emmanuel; Simard, Chantale
Keywords: Antimitotiques; Cancers Colorectaux; Cancers Colorectaux Métastatiques Et Chimiorésistants; Chimiothérapie Personnalisée; Développement De Médicaments Anticancéreux; Modulateurs D'Ahr; Promédicaments Antimicrotubules
L'AIMZ-938, un nouveau promédicament anticancéreux pour le traitement des cancers du sein humain réfractaires aux traitements actuels et exprimant le cytochrome P450 1A1
Principal investigators: Fortin, Sébastien
Keywords: Antimitotiques; Cancers Du Sein; Cancers Du Sein Chimiorésistants; Cancers Du Sein Triple Négatifs; Chimiothérapie Personnalisée; Développement De Médicaments Anticancéreux; Promédicaments Antimicrotubules
Validation of Highly Potent Substituted Phenyl Alkylureas as Antipsoriatic Agents
Principal investigators: C.-Gaudreault, René
Keywords: Anti-Inflammatory Drugs; Cytokines; Drugs; Inflammatory Diseases; Mechanism Of Action; Medicinal Chemistry; Molecular Pharmacology; Psoriasis
Substituted phenyl alkylureas as new potent antipsoriatic drugs: Mechanism of action and structure-activity relationships
Principal investigators: C.-Gaudreault, René
Keywords: Drugs; Mechanism Of Action; Molecular Pharmacology; Psoriasis; Psoriasis Mode
Comprendre le rôle des cellules immunitaires dans le psoriasis grâce au génie tissulaire
Principal investigators: Pouliot, Roxane
Keywords: Différenciation Cellulaire; Greffe; Génie Tissulaire; Immunologie; Peau; Peau Reconstruite; Psoriasis; Substituts Pathologiques
Optimization and Validation of Highly Cytocidal Substituted Phenyl Imidazolidin-2-one as Antimicrotubule Agents for Cancer Chemotherapy
Principal investigators: C.-Gaudreault, René
Keywords: Anticancer Drug; Cancer; Drug Evaluation; Medicinal Chemistry
Protoemics: In-gel automated digester and MALDI-TOF spotter
Principal investigators: Poirier, Guy
Purchase of a MALDI-TOF (Matrix assisted laser desorption/ionisation time-of-flight) mass spectrometer
Principal investigators: Poirier, Guy
Design and evaluation of pure polyamine transport antagonists as antitumour reagents
Principal investigators: Poulin, Richard
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.